Children's Memorial Hospital/Division of Hematology/Oncology — Chicago, Illinois

Children's Memorial Hospital/Division of Hematology/Oncology is a clinical research site located in Chicago, Illinois, United States 60614-3394.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Children's Memorial Hospital/Division of Hematology/Oncology has participated in 1 clinical trials.

Therapeutic areas: Non-transfusion Dependent Thalassemia.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Children's Memorial Hospital/Division of Hematology/Oncology?

Children's Memorial Hospital/Division of Hematology/Oncology has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Children's Memorial Hospital/Division of Hematology/Oncology conducted?

Children's Memorial Hospital/Division of Hematology/Oncology has 1 clinical trials on record. Their work covers Non-transfusion Dependent Thalassemia.

Is Children's Memorial Hospital/Division of Hematology/Oncology accredited by Crixeo Clinical Trials?

Children's Memorial Hospital/Division of Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Children's Memorial Hospital/Division of Hematology/Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.